Schwann cell proliferation of the cecal appendix: Intramucosal variant
Ann Pathol. 2024 Mar 21:S0242-6498(24)00072-5. doi: 10.1016/j.annpat.2024.03.001. Online ahead of print.NO ABSTRACTPMID:38519385 | DOI:10.1016/j.annpat.2024.03.001 (Source: Annales de Pathologie)
Source: Annales de Pathologie - March 22, 2024 Category: Pathology Authors: Javier Arredondo Montero Rosa Guarch Troyas Source Type: research

Schwann cell proliferation of the cecal appendix: Intramucosal variant
Ann Pathol. 2024 Mar 21:S0242-6498(24)00072-5. doi: 10.1016/j.annpat.2024.03.001. Online ahead of print.NO ABSTRACTPMID:38519385 | DOI:10.1016/j.annpat.2024.03.001 (Source: Annales de Pathologie)
Source: Annales de Pathologie - March 22, 2024 Category: Pathology Authors: Javier Arredondo Montero Rosa Guarch Troyas Source Type: research

Schwann cell proliferation of the cecal appendix: Intramucosal variant
Ann Pathol. 2024 Mar 21:S0242-6498(24)00072-5. doi: 10.1016/j.annpat.2024.03.001. Online ahead of print.NO ABSTRACTPMID:38519385 | DOI:10.1016/j.annpat.2024.03.001 (Source: Annales de Pathologie)
Source: Annales de Pathologie - March 22, 2024 Category: Pathology Authors: Javier Arredondo Montero Rosa Guarch Troyas Source Type: research

Schwann cell proliferation of the cecal appendix: Intramucosal variant
Ann Pathol. 2024 Mar 21:S0242-6498(24)00072-5. doi: 10.1016/j.annpat.2024.03.001. Online ahead of print.NO ABSTRACTPMID:38519385 | DOI:10.1016/j.annpat.2024.03.001 (Source: Annales de Pathologie)
Source: Annales de Pathologie - March 22, 2024 Category: Pathology Authors: Javier Arredondo Montero Rosa Guarch Troyas Source Type: research

Editorial
Ann Pathol. 2024 Mar;44(2):87. doi: 10.1016/j.annpat.2024.02.010.NO ABSTRACTPMID:38508841 | DOI:10.1016/j.annpat.2024.02.010 (Source: Annales de Pathologie)
Source: Annales de Pathologie - March 20, 2024 Category: Pathology Authors: Audrey Rousseau Source Type: research

Editorial
Ann Pathol. 2024 Mar;44(2):87. doi: 10.1016/j.annpat.2024.02.010.NO ABSTRACTPMID:38508841 | DOI:10.1016/j.annpat.2024.02.010 (Source: Annales de Pathologie)
Source: Annales de Pathologie - March 20, 2024 Category: Pathology Authors: Audrey Rousseau Source Type: research

Editorial
Ann Pathol. 2024 Mar;44(2):87. doi: 10.1016/j.annpat.2024.02.010.NO ABSTRACTPMID:38508841 | DOI:10.1016/j.annpat.2024.02.010 (Source: Annales de Pathologie)
Source: Annales de Pathologie - March 20, 2024 Category: Pathology Authors: Audrey Rousseau Source Type: research

Contribution of connected prescriptions (NetSIG) for the management of molecular pathology exams
CONCLUSION: Connected prescriptions made this complex circuit more fluid and facilitated the redistribution of different administrative and technical tasks. The number of phone calls decreased sharply. Half of the prescriptions were made by pathologists and half by oncologists (physicians or secretaries). The mean dearchiving duration for blocks was one day. Mean forwarding of blocks was 2.5 days. Mean turnaround time was 8 days for targeted techniques and 13 days for Next Generation Sequencing. Physicians appreciated the interactivity of the software and the fact that they could consult it on a smartphone.PMID:38503611 | ...
Source: Annales de Pathologie - March 19, 2024 Category: Pathology Authors: Laurent Martin Caroline Chapusot Georges Tarris Alicia Remond Alice Milli ère C élia Pioche Jessie Dubois Nathalie Laffage Manon Aubry Lyse Marie Dubois Haingo Andrianiaina Noelle Provost Mathilde Funes de la Vega Nad ège Grangier Fara Harizay Catherin Source Type: research

An emerging lymphoproliferative disorder
Ann Pathol. 2024 Mar 18:S0242-6498(24)00071-3. doi: 10.1016/j.annpat.2024.02.011. Online ahead of print.NO ABSTRACTPMID:38503612 | DOI:10.1016/j.annpat.2024.02.011 (Source: Annales de Pathologie)
Source: Annales de Pathologie - March 19, 2024 Category: Pathology Authors: Nathana ël Fort Antoine Taillandier Rapha ëlle Binois R émy Kerdraon Thibault Kervarrec Flore Delalande Source Type: research

Salivary gland tumors: 2022 WHO blue book and beyond
Ann Pathol. 2024 Mar 5:S0242-6498(24)00046-4. doi: 10.1016/j.annpat.2024.02.005. Online ahead of print.ABSTRACTIn 2022, the 5th edition of the WHO classification of Head and Neck tumors was published online. In the salivary gland chapter, a new benign entity, the keratocystoma, was introduced. The sclerosing polycystic adenosis has been recognized as tumoral and is now termed sclerosing polycystic adenoma. The striated duct adenoma now has its own dedicated chapter. Additionally, a new variant of pleomorphic adenoma, termed "canalicular adenoma-like," has been incorporated. Regarding malignant tumors of the salivary glands...
Source: Annales de Pathologie - March 6, 2024 Category: Pathology Authors: Charles L épine Source Type: research

Ossifying Fibromyxoid Tumor (OFMT) of the Cheek: A Distinct Soft Tissue Neoplasm
Ann Pathol. 2024 Mar 5:S0242-6498(24)00044-0. doi: 10.1016/j.annpat.2024.02.003. Online ahead of print.NO ABSTRACTPMID:38448263 | DOI:10.1016/j.annpat.2024.02.003 (Source: Annales de Pathologie)
Source: Annales de Pathologie - March 6, 2024 Category: Pathology Authors: Nada Shaker Nuha Shaker Dinesh Pradhan Rafat Abu Shakra Omar P Sangueza Source Type: research

A deceptively alarming "balloon release"!
Ann Pathol. 2024 Mar 5:S0242-6498(24)00049-X. doi: 10.1016/j.annpat.2024.02.008. Online ahead of print.NO ABSTRACTPMID:38448264 | DOI:10.1016/j.annpat.2024.02.008 (Source: Annales de Pathologie)
Source: Annales de Pathologie - March 6, 2024 Category: Pathology Authors: Arnault Tauzi ède-Espariat Bertrand Grand Ali Benali Marie Georges Thomas Rialland Odette Georges Source Type: research

Radiation-induced parotid leiomyosarcoma
DISCUSSION: This is the first case of radiation-induced leiomyosarcoma and the 12th case of parotid leiomyosarcoma described in the literature. The management associates surgery with adjuvant radiotherapy. Follow-up is by clinical examination, parotid MRI, and annual thoracoabdominal CT scan to search for metastases. Recurrences occur during the first year in 40 to 64% of cases, and distant metastases in 40 to 60% of cases. The 5-year survival rate is between 10 and 30%.PMID:38448265 | DOI:10.1016/j.annpat.2024.02.007 (Source: Annales de Pathologie)
Source: Annales de Pathologie - March 6, 2024 Category: Pathology Authors: Luc Boullaud Anne Marie Bergemer Fabrice Micaletti Lea Periers David Bakhos Source Type: research

Basal cell carcinoma with myoepithelial differentiation
Ann Pathol. 2024 Mar 5:S0242-6498(24)00045-2. doi: 10.1016/j.annpat.2024.02.004. Online ahead of print.NO ABSTRACTPMID:38448266 | DOI:10.1016/j.annpat.2024.02.004 (Source: Annales de Pathologie)
Source: Annales de Pathologie - March 6, 2024 Category: Pathology Authors: Claire David Antoine Taillandier Paul-Louis Chantreau R émy Kerdraon Flore Delalande Patrick Michenet Source Type: research

Salivary gland tumors: 2022 WHO blue book and beyond
Ann Pathol. 2024 Mar 5:S0242-6498(24)00046-4. doi: 10.1016/j.annpat.2024.02.005. Online ahead of print.ABSTRACTIn 2022, the 5th edition of the WHO classification of Head and Neck tumors was published online. In the salivary gland chapter, a new benign entity, the keratocystoma, was introduced. The sclerosing polycystic adenosis has been recognized as tumoral and is now termed sclerosing polycystic adenoma. The striated duct adenoma now has its own dedicated chapter. Additionally, a new variant of pleomorphic adenoma, termed "canalicular adenoma-like," has been incorporated. Regarding malignant tumors of the salivary glands...
Source: Annales de Pathologie - March 6, 2024 Category: Pathology Authors: Charles L épine Source Type: research